HomeCompareEKGGF vs SBUX

EKGGF vs SBUX: Dividend Comparison 2026

EKGGF yields 43478.26% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EKGGF wins by $1.1890295911865906e+23M in total portfolio value
10 years
EKGGF
EKGGF
● Live price
43478.26%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.1890295911865906e+23M
Annual income
$118,367,411,904,190,840,000,000,000,000.00
Full EKGGF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — EKGGF vs SBUX

📍 EKGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEKGGFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EKGGF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EKGGF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EKGGF
Annual income on $10K today (after 15% tax)
$3,695,652.17/yr
After 10yr DRIP, annual income (after tax)
$100,612,300,118,562,220,000,000,000,000.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, EKGGF beats the other by $100,612,300,118,562,220,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EKGGF + SBUX for your $10,000?

EKGGF: 50%SBUX: 50%
100% SBUX50/50100% EKGGF
Portfolio after 10yr
$5.945147955932953e+22M
Annual income
$59,183,705,952,095,420,000,000,000,000.00/yr
Blended yield
99.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

EKGGF
No analyst data
Altman Z
-198.7
Piotroski
1/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EKGGF buys
0
SBUX buys
0
No recent congressional trades found for EKGGF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEKGGFSBUX
Forward yield43478.26%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$1.1890295911865906e+23M$157.5K
Annual income after 10y$118,367,411,904,190,840,000,000,000,000.00$65,840.13
Total dividends collected$1.1886778493816057e+23M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: EKGGF vs SBUX ($10,000, DRIP)

YearEKGGF PortfolioEKGGF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$4,358,526$4,347,826.09$11,107$407.21+$4.35MEKGGF
2$1,775,702,260$1,771,038,637.53$12,512$626.87+$1775.69MEKGGF
3$676,233,533,658$674,333,532,239.80$14,366$978.69+$676233.52MEKGGF
4$240,727,047,188,757$240,003,477,307,741.90$16,929$1,557.50+$240727047.17MEKGGF
5$80,105,191,727,727,180$79,847,613,787,235,220.00$20,658$2,543.80+$80105191727.71MEKGGF
6$24,917,840,645,043,868,000$24,832,128,089,895,195,000.00$26,406$4,302.22+$24917840645043.84MEKGGF
7$7,245,709,632,152,810,000,000$7,219,047,542,662,613,000,000.00$35,877$7,622.00+$7245709632152810.00MEKGGF
8$1,969,606,736,781,993,500,000,000$1,961,853,827,475,589,700,000,000.00$52,741$14,352.64+$1969606736781993472.00MEKGGF
9$500,511,415,390,858,850,000,000,000$498,403,936,182,502,200,000,000,000.00$85,676$29,243.03+$500511415390858838016.00MEKGGF
10$118,902,959,118,659,060,000,000,000,000$118,367,411,904,190,840,000,000,000,000.00$157,513$65,840.13+$1.1890295911865906e+23MEKGGF

EKGGF vs SBUX: Complete Analysis 2026

EKGGFStock

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company's technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its proprietary device connectivity and ECG management technologies are used in medical, consumer, clinical research, and telemedicine solutions. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders, as well as HeartCheck CardiBeat. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring. Additionally, the company provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.

Full EKGGF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this EKGGF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EKGGF vs SCHDEKGGF vs JEPIEKGGF vs OEKGGF vs KOEKGGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.